Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production

Influenza and other Respiratory Viruses

Volumn 3, Issue 6, 2009, Pages 287-295

  Dong, Jie ^a   Matsuoka, Yumiko ^b   Maines, Taronna R ^b   Swayne, David E ^c   O'Neill, Eduardo ^b   Davis, C Todd ^b   Van Hoven, Neal ^b   Balish, Amanda ^b   Yu, Hong Jie ^a   Katz, Jacqueline M ^b   Klimov, Alexander ^b   Cox, Nancy ^b   Li, De Xin ^a   Wang, Yu ^a   Guo, Yuan Ji ^a   Yang, Wei Zhong ^a   Donis, Ruben O ^b   Shu, Yue Long ^a  

^a National Institute for Viral Disease Control and Prevention   (China)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

H5N1 vaccine; Pandemic influenza; Seed virus

Indexed keywords

DNA; HEMAGGLUTININ; INFLUENZA VACCINE; SIALIDASE;

ANIMAL CELL; ANTIGENICITY; ARTICLE; AVIAN INFLUENZA; CELL STRAIN HEK293; CHICKEN; CHINA; CLADISTICS; DNA TRANSFECTION; DRUG SAFETY; EMBRYO; FERRET; FIBROBLAST; GENE REPLICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; LAOS; NONHUMAN; PANDEMIC; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH; THAILAND; VACCINE PRODUCTION; VIET NAM; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; BIRDS; BRAIN; CHICK EMBRYO; CHICKENS; CLUSTER ANALYSIS; DISEASE OUTBREAKS; FEMALE; FERRETS; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUNG; MALE; ORTHOMYXOVIRIDAE INFECTIONS; PHYLOGENY; PLAQUE ASSAY; PREGNANCY; REASSORTANT VIRUSES; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SPLEEN; SURVIVAL ANALYSIS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRULENCE;

EID: 70449359942     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2009.00104.x     Document Type: Article

References (35)

1. Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 2005, 3:591-600.
2. Gillim-Ross L, Subbarao K. Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev 2006, 19:614-636.
3. Schafer JR, Kawaoka Y, Bean WJ, Suss J, Senne D, Webster RG. Origin of the pandemic 1957 H2 influenza a virus and the persistence of its possible progenitors in the avian reservoir. Virol 1993, 194:781-788.
4. Subbarao K, Joseph T. Scientific barriers to developing vaccines against avian influenza viruses. Nat Rev Immunol 2007, 7:267-278.
5. Scholtissek C, Rohde W, Von H V, Rott R. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virol 1978, 87:13-20.
6. Fouchier RA, Munster V, Wallensten A. Characterization of a novel influenza a virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005, 79:2814-2822.
7. Myers KP, Setterquist SF, Capuano AW, Gray GC. Infection due to 3 avian influenza subtypes in United States veterinarians. Clin Infect Dis 2007, 45:4-9.
8. Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis 2006, 194(Suppl. 2):S111-S118.
9. Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2008, 14:e1.
10. Antigenic and genetic characteristics of H5N1 viruses and candidate h5n1 vaccine viruses developed for potential use in human vaccines. 2008, http://www.Who.Int/csr/disease/avian_influenza/guidelines/200809_h5vacci nevirusupdate.Pdf
11. Wu WL, Chen Y, Wang P. Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol 2008, 82:1798-1807.
12. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006, 312:404-410.
13. Wilson IA, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 1990, 8:737-771.
14. A description of the process of seasonal and H5N1 influenza vaccine virus selection and development. 2007, http://www.Who.Int/csr/disease/avian_influenza/influenza_vaccine-virus_s lection/en/index.Html
15. Nicolson C, Major D, Wood JM, Robertson JS. Generation of influenza vaccine viruses on vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 2005, 23:2943-2952.
16. Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 2005, 11:1515-1521.
17. Shu Y, Yu H, Li D. Lethal avian influenza a (H5N1) infection in a pregnant woman in Anhui province, china. N Engl J Med 2006, 354:1421-1422.
18. Stephenson I, Wood JM, Nicholson KG, Charlett A, Zambon MC. Detection of anti-H5 responses in human sera by HI using horse erythrocytes following mf59-adjuvanted influenza a/duck/singapore/97 vaccine. Virus Res 2004, 103:91-95.
19. Subbarao K, Chen H, Swayne D. Evaluation of a genetically modified reassortant H5N1 influenza a virus vaccine candidate generated by plasmid-based reverse genetics. Virol 2003, 305:192-200.
20. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. Universal primer set for the full-length amplification of all influenza a viruses. Arch Virol 2001, 146:2275-2289.
21. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A. Rescue of influenza a virus from recombinant DNA. J Virol 1999, 73:9679-9682.
22. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938, 27:493-497.
23. Hirst GK. The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus. Science 1941, 94:22-23.
24. Klenk HD, Rott R, Orlich M, Blodorn J. Activation of influenza a viruses by trypsin treatment. Virol 1975, 68:426-439.
25. Manual of diagnostic tests and vaccines for terrestrial animals. Chapter 2.1.14. 2008, http://www.Oie.Int/eng/normes/mmanual/a_summry.Htm
26. Kendal AP, Pereira MS, Skehel JJ. Concepts and Procedures for Laboratory-Based Influenza Surveillance 1982, Atlanta, US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention
27. Garten W, Linder D, Rott R, Klenk HD. The cleavage site of the hemagglutinin of fowl plague virus. Virol 1982, 122:186-190.
28. Swayne DE, Pantin-Jackwood M. Pathogenicity of avian influenza viruses in poultry. Dev Biol (Basel) 2006, 124:61-67.
29. Maines TR, Chen LM, Matsuoka Y. Lack of transmission of h5n1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci USA 2006, 103:12121-12126.
30. Maines TR, Lu XH, Erb SM. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 2005, 79:11788-11800.
31. Hay AJ, Gregory V, Douglas AR, Lin YP. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 2001, 356:1861-1870.
32. Nelson MI, Simonsen L, Viboud C. Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog 2006, 2:1144-1151.
33. Couch RB, Kasel JA, Glezen WP. Influenza: its control in persons and populations. J Infect Dis 1986, 153:431-440.
34. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972, 70:767-777.
35. Who biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines. Adopted by the 56th meeting of the WHO expert committee on biological standardization. 2005, http://www.Who.Int/biologicals/publications/ecbs%202005%20annex%205%20in fluenza.Pdf